Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...
Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...
Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...
Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...
Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories ...
Depression often manifests through persistent sadness, fatigue, and loss of interest. Recognizing these symptoms can ...
Living with fructose intolerance can be downright debilitating. Here, one writer shares the physical and mental health impact ...
Depression is a complex disorder that affects people in various ways, influencing mood, thoughts, behavior, and even physical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback